Citations

Citations to this article as recorded by  

• Sesquiterpene Lactones as Promising Anti-Glioblastoma Drug Candidates Exerting Complex Effects on Glioblastoma Cell Viability and Proneural–Mesenchymal Transition
  Andrey V. Markov, Arseny D. Moralev, Kirill V. Odarenko
  Biomedicines.2025; 13(1): 133.     CrossRef
• Sesquiterpene lactones and cancer: new insight into antitumor and anti-inflammatory effects of parthenolide-derived Dimethylaminomicheliolide and Micheliolide
  Jian Li, Xin Li, Hongwei Liu
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Sesquiterpene Lactones as Promising Phytochemicals to Cease Metastatic Propagation of Cancer
  Fatemeh Mehdikhani, Homa Hajimehdipoor, Mojgan Tansaz, Marc Maresca, Sadegh Rajabi
  Biomolecules.2025; 15(2): 268.     CrossRef
• Cumin (Cuminum cyminum L.) seeds accelerates wound healing in rats: Possible molecular mechanisms
  Khaled Abdul‐Aziz Ahmed, Ahmed A. J. Jabbar, Yaseen Galali, Ayman M. Al‐Qaaneh, Gökhan Akçakavak, Nur Ain Salehen, Rawaz Rizgar Hassan, Ramzi A. Mothana, Mahmood Ameen Abdulla, Omer I. Fantoukh, Sidig Hasson, Mohammed F. Hawwal
  Skin Research and Technology.2024;[Epub]     CrossRef
• TGFβ in Pancreas and Colorectal Cancer: Opportunities to Overcome Therapeutic Resistance
  Allan M. Johansen, Steven D. Forsythe, Callum T. McGrath, Grayson Barker, Hugo Jimenez, Ravi K. Paluri, Boris C. Pasche
  Clinical Cancer Research.2024; 30(17): 3676.     CrossRef
• NF-κB pathway and angiogenesis: insights into colorectal cancer development and therapeutic targets
  Ashkan Bahrami, Amirreza Khalaji, Majed Bahri Najafi, Sina Sadati, Arash Raisi, AmirMohammad Abolhassani, Reza Eshraghi, Mahmood Khaksary Mahabady, Neda Rahimian, Hamed Mirzaei
  European Journal of Medical Research.2024;[Epub]     CrossRef
• Bitter taste signaling in cancer
  Ana R. Costa, Ana C. Duarte, Ana R. Costa-Brito, Isabel Gonçalves, Cecília R.A. Santos
  Life Sciences.2023; 315: 121363.     CrossRef
• Parthenolide inhibits proliferation and invasion, promotes apoptosis, and reverts the cell–cell adhesion loss through downregulation of NF‐κB pathway TNF‐α‐activated in colorectal cancer cells
  Adriana S. Gehren, Waldemir F. de Souza, Annie C. M. Sousa‐Squiavinato, Diego A. A. Ramos, Bruno R. B. Pires, Eliana S. F. W. Abdelhay, Jose A. Morgado‐Diaz
  Cell Biology International.2023; 47(9): 1638.     CrossRef
• Parthenolide repressed endometriosis induced surgically in rats: Role of PTEN/PI3Kinase/AKT/GSK-3β/β-catenin signaling in inhibition of epithelial mesenchymal transition
  Soad L. Kabil, Hayam E. Rashed, Noura Mostafa Mohamed, Nisreen E. Elwany
  Life Sciences.2023; 331: 122037.     CrossRef
• TGF-β in correlation with tumor progression, immunosuppression and targeted therapy in colorectal cancer
  Sumeet Singh, Vinita Gouri, Mukesh Samant
  Medical Oncology.2023;[Epub]     CrossRef
• The Emerging Potential of Parthenolide Nanoformulations in Tumor Therapy
  Tao An, Huanhuan Yin, Yanting Lu, Feng Liu
  Drug Design, Development and Therapy.2022; Volume 16: 1255.     CrossRef
• Parthenolide reverses the epithelial to mesenchymal transition process in breast cancer by targeting TGFbeta1: In vitro and in silico studies
  Hazera Binte Sufian, Julianna Maria Santos, Zeina S. Khan, Sobia Ahsan Halim, Ajmal Khan, Maliha Tabassum Munir, MD Khurshidul Zahid, Ahmed Al-Harrasi, Lauren S. Gollahon, Fazle Hussain, Shaikh Mizanoor Rahman
  Life Sciences.2022; 301: 120610.     CrossRef
• Cinnamomum bejolghota Extract Inhibits Colorectal Cancer Cell Metastasis and TGF-β1-Induced Epithelial-Mesenchymal Transition via Smad and Non-Smad Signaling Pathway
  Athicha Kittiwattanokhun, Sukanda Innajak, Etsu Tashiro, Masaya Imoto, Ramida Watanapokasin
  Scientia Pharmaceutica.2022; 90(2): 30.     CrossRef
• Autoimmunity and Cancer—Two Sides of the Same Coin
  Justyna Sakowska, Łukasz Arcimowicz, Martyna Jankowiak, Ines Papak, Aleksandra Markiewicz, Katarzyna Dziubek, Małgorzata Kurkowiak, Sachin Kote, Karolina Kaźmierczak-Siedlecka, Karol Połom, Natalia Marek-Trzonkowska, Piotr Trzonkowski
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Sesquiterpene Lactones and Cancer: New Insight into Antitumor and Anti-inflammatory Effects of Parthenolide-Derived Dimethylaminomicheliolide and Micheliolide
  Yubo Dong, Xuanjin Qian, Jian Li, Ahmed Faeq Hussein
  Computational and Mathematical Methods in Medicine.2022; 2022: 1.     CrossRef
• Plants as a Source of Anticancer Agents: From Bench to Bedside
  Wamidh H. Talib, Safa Daoud, Asma Ismail Mahmod, Reem Ali Hamed, Dima Awajan, Sara Feras Abuarab, Lena Hisham Odeh, Samar Khater, Lina T. Al Kury
  Molecules.2022; 27(15): 4818.     CrossRef
• Pharmacological Targeting of Epithelial-to-Mesenchymal Transition in Colorectal Cancer
  Nima Zafari, Mahla Velayati, Mohammadreza Nassiri, Majid Khazaei, Seyed Mahdi Hassanian, Gordon A. Ferns, Amir Avan
  Current Pharmaceutical Design.2022; 28(28): 2298.     CrossRef
• The mechanism of sitagliptin inhibition of colorectal cancer cell lines' metastatic functionalities
  Rubén Varela‐Calviño, Marta Rodríguez‐Quiroga, Patrícia Dias Carvalho, Flavia Martins, André Serra‐Roma, Lorena Vázquez‐Iglesias, María Páez de la Cadena, Sérgia Velho, Oscar J. Cordero
  IUBMB Life.2021; 73(5): 761.     CrossRef

• Parthenolide Inhibits Angiogenesis in Esophageal Squamous Cell Carcinoma Through Suppression of VEGF

  
  Bo Tian, Yuhang Xiao, Junliang Ma, Wei Ou, Hui Wang, Jie Wu, Jinming Tang, Baihua Zhang, Xiaojuan Liao, Desong Yang, Zhining Wu, Xu Li, Yong Zhou, Min Su, Wenxiang Wang
  OncoTargets and Therapy.2020; Volume 13: 7447.     CrossRef
• Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity
  Alex S. Quy, Xingjian Li, Louise Male, Tatjana Stankovic, Angelo Agathanggelou, John S. Fossey
  Tetrahedron.2020; : 131631.     CrossRef
• Reversal of Epithelial–Mesenchymal Transition by Natural Anti-Inflammatory and Pro-Resolving Lipids
  Chang Hoon Lee
  Cancers.2019; 11(12): 1841.     CrossRef

Citations

Citations to this article as recorded by  

• Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer
  Chin King Looi, Ling-Wei Hii, Felicia Fei-Lei Chung, Chun-Wai Mai, Wei-Meng Lim, Chee-Onn Leong
  Cancers.2021; 13(8): 1786.     CrossRef
• Computational investigation of FDA approved drugs as selective PARP-1 inhibitors by targeting BRCT domain for cancer therapy
  Chandan Kumar, P.T.V. Lakshmi, Annamalai Arunachalam
  Journal of Molecular Graphics and Modelling.2021; 108: 107919.     CrossRef
• Identification of Autophagy-Associated Biomarkers and Corresponding Regulatory Factors in the Progression of Colorectal Cancer
  Chunrui Zhang, Jing Jiang, Liqiang Wang, Liyu Zheng, Jiankai Xu, Xiaolin Qi, Huiying Huang, Jianping Lu, Kongning Li, Hong Wang
  Frontiers in Genetics.2020;[Epub]     CrossRef
• Anticancer and apoptotic activities of parthenolide in combination with epirubicin in mda-mb-468 breast cancer cells
  Arash Ghorbani-Abdi-Saedabad, Mohammad Yahya Hanafi-Bojd, Negin Parsamanesh, Zahra Tayarani-Najaran, Homa Mollaei, Reyhane Hoshyar
  Molecular Biology Reports.2020; 47(8): 5807.     CrossRef
• Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies
  Malgorzata Sztiller-Sikorska, Malgorzata Czyz
  Pharmaceuticals.2020; 13(8): 194.     CrossRef
• Integration of genetic variants and gene network for drug repurposing in colorectal cancer
  Lalu Muhammad Irham, Henry Sung-Ching Wong, Wan-Hsuan Chou, Wirawan Adikusuma, Eko Mugiyanto, Wan-Chen Huang, Wei-Chiao Chang
  Pharmacological Research.2020; 161: 105203.     CrossRef
• Synthesis of azo dyes possessing N-heterocycles and evaluation of their anticancer and antibacterial properties
  Zarrin Ghasemi, Sajjad Azizi, Roya Salehi, Hossein Samadi Kafil
  Monatshefte für Chemie - Chemical Monthly.2018; 149(1): 149.     CrossRef
• Parthenolide attenuated bleomycin-induced pulmonary fibrosis via the NF-κB/Snail signaling pathway
  Xiao-he Li, Ting Xiao, Jia-huan Yang, Yuan Qin, Jing-jing Gao, Hui-juan Liu, Hong-gang Zhou
  Respiratory Research.2018;[Epub]     CrossRef
• Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth
  Eun-Kyung Kim, Jae Hee Cho, EuiJoo Kim, Yoon Jae Kim, Aamir Ahmad
  PLOS ONE.2017; 12(7): e0181183.     CrossRef
• Dietary selenium protects adiponectin knockout mice against chronic inflammation induced colon cancer
  Arpit Saxena, Raja Fayad, Kamaljeet Kaur, Samantha Truman, Julian Greer, James A. Carson, Anindya Chanda
  Cancer Biology & Therapy.2017; 18(4): 257.     CrossRef
• Sesquiterpene binding Gly-Leu-Ser/Lys-“co-adaptation pocket” to inhibit lung cancer cell epithelial-mesenchymal transition
  Xiao-Yu Ai, Heng Zhang, Shao-Yan Gao, Yuan Qin, Wei-Long Zhong, Ju Gu, Meng Li, Kai-Liang Qiao, Qin Tian, Zhan-Hong Cui, Jia-Huan Yang, Zhun Bi, Ting Xiao, Shuang Chen, Hui-Juan Liu, Hong-Gang Zhou, Tao Sun, Cheng Yang
  Oncotarget.2017; 8(41): 70192.     CrossRef
• Juglanin inhibits lung cancer by regulation of apoptosis, ROS and autophagy induction
  Liang Chen, Ya-Qiong Xiong, Jing Xu, Ji-Peng Wang, Zi-Li Meng, Yong-Qing Hong
  Oncotarget.2017; 8(55): 93878.     CrossRef
• Cyr61 participates in the pathogenesis of acute lymphoblastic leukemia by enhancing cellular survival via the AKT/NF-κB signaling pathway
  Xianjin Zhu, Yanfang Song, Conglian Wu, Chuxi Pan, Pingxia Lu, Meihua Wang, Peizheng Zheng, Rongfen Huo, Chenqing Zhang, Wanting Li, Yulin Lin, Yingping Cao, Ningli Li
  Scientific Reports.2016;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Is Metformin Associated with a Lower Prevalence of Polyps, Adenomas, and Colorectal Carcinoma in Patients with Diabetes Mellitus?
  Maria Inês Canha, Gonçalo Ramos, Rita Prata, Pedro Lages Martins, Marta Viúla Ramos, João Coimbra
  Journal of Gastrointestinal Cancer.2024; 55(1): 435.     CrossRef
• Metformin administration in prevention of colorectal polyps in type 2 diabetes mellitus patients
  Xiao-Qing Wu, Li-Hua Deng, Qian Xue, Xia Li, Meng-Han Li, Jing-Tong Wang
  World Journal of Clinical Cases.2024; 12(20): 4206.     CrossRef
• Anti-cancer Efficacy of Metformin: Recent Updates on Breast and Other Cancers
  Md. Imtiazul Kabir, Robin Kumar, Lakshmi Sai Pratyusha Bugata, Komal Raina
  Current Pharmacology Reports.2023; 9(5): 284.     CrossRef
• Metformin Use Is Inversely Associated with Prevalent, but Not Incident Colorectal Adenomas
  Anna Krigel, Snow Trinh T. Nguyen, Nawar Talukder, Ching-Ho Huang, Carlos Buitrago, Gabriel Karkenny, Benjamin Lebwohl, Julian A. Abrams, James L. Araujo
  Digestive Diseases and Sciences.2022; 67(10): 4886.     CrossRef
• Effect of metformin on thyroid cancer risk in patients with acromegaly: A preliminary observational study
  Cem Sulu, Ayyuce Begum Bektas, Suleyman Sami Guzel, Kubilay Tay, Serdar Sahin, Emre Durcan, Hande Mefkure Ozkaya, Pinar Kadioglu
  Growth Hormone & IGF Research.2022; 66: 101484.     CrossRef
• Metformin Modifies the Gut Microbiota of Mice Infected with Helicobacter pylori
  Marine Jauvain, Sarah Courtois, Philippe Lehours, Emilie Bessède
  Pharmaceuticals.2021; 14(4): 329.     CrossRef
• Bovine Meat and Milk Factors (BMMFs): Their Proposed Role in Common Human Cancers and Type 2 Diabetes Mellitus
  Ethel-Michele de Villiers, Harald zur Hausen
  Cancers.2021; 13(21): 5407.     CrossRef
• Suppressive effects of metformin on colorectal adenoma incidence and malignant progression
  Min Deng, Siqin Lei, Dongdong Huang, Hui Wang, Shuli Xia, Enping Xu, Yihua Wu, Honghe Zhang
  Pathology - Research and Practice.2020; 216(2): 152775.     CrossRef
• Use of metformin and risk of breast and colorectal cancer
  Gad Rennert, Hedy S. Rennert, Naomi Gronich, Mila Pinchev, Stephen B. Gruber
  Diabetes Research and Clinical Practice.2020; 165: 108232.     CrossRef
• Diabetes Mellitus: a Clinical Condition Associated with Metabolic Syndrome and Colorectal Cancer Risk
  Vesna Brzacki, Aleksandar Nagorni, Manolis Kallistratos, Athanasios Manolis, Dragan Lovic
  Current Pharmacology Reports.2019; 5(4): 205.     CrossRef
• Diabetes Mellitus and Colon Carcinogenesis: Expectation for Inhibition of Colon Carcinogenesis by Oral Hypoglycemic Drugs
  Junichi Kato, Yohei Shirakami, Masahito Shimizu
  Gastrointestinal Disorders.2019; 1(2): 273.     CrossRef
• Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects
  Muhamad Noor Alfarizal Kamarudin, Md. Moklesur Rahman Sarker, Jin-Rong Zhou, Ishwar Parhar
  Journal of Experimental & Clinical Cancer Research.2019;[Epub]     CrossRef
• Postoperative adjuvant chemotherapy is associated with a lower incidence of colorectal adenomas in patients with previous colorectal cancer
  Hee Seung Lee, Sung Bae Kim, Hyun Jung Lee, Soo Jung Park, Sung Pil Hong, Jae Hee Cheon, Won Ho Kim, Tae Il Kim
  Gastrointestinal Endoscopy.2018; 87(3): 688.     CrossRef
• Parameters of Glucose and Lipid Metabolism Affect the Occurrence of Colorectal Adenomas Detected by Surveillance Colonoscopies
  Nam Hee Kim, Jung Yul Suh, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Kyuyong Choi, Yoon Suk Jung
  Yonsei Medical Journal.2017; 58(2): 347.     CrossRef
• Diabetes-induced mechanophysiological changes in the small intestine and colon
  Mirabella Zhao, Donghua Liao, Jingbo Zhao
  World Journal of Diabetes.2017; 8(6): 249.     CrossRef
• Metformin use and the risk of colorectal adenoma: A systematic review and meta‐analysis
  Yoon Suk Jung, Chan Hyuk Park, Chang Soo Eun, Dong Il Park, Dong Soo Han
  Journal of Gastroenterology and Hepatology.2017; 32(5): 957.     CrossRef
• Energy sensing pathways: Bridging type 2 diabetes and colorectal cancer?
  Juhong Yang, Reiko Nishihara, Xuehong Zhang, Shuji Ogino, Zhi Rong Qian
  Journal of Diabetes and its Complications.2017; 31(7): 1228.     CrossRef
• Metformin therapy and the risk of colorectal adenoma in patients with type 2 diabetes: A meta-analysis
  Yi-Chao Hou, Qiang Hu, Jiao Huang, Jing-Yuan Fang, Hua Xiong
  Oncotarget.2017; 8(5): 8843.     CrossRef
• Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis
  Feifei Liu, Lijing Yan, Zhan Wang, Yuanan Lu, Yuanyuan Chu, Xiangyu Li, Yisi Liu, Dongsheng Rui, Shaofa Nie, Hao Xiang
  Oncotarget.2017; 8(9): 16017.     CrossRef
• Therapeutic strategies against cancer stem cells in human colorectal cancer (Review)
  Magdalena Szaryńska, Agata Olejniczak, Jarosław Kobiela, Piotr Spychalski, Zbigniew Kmieć
  Oncology Letters.2017;[Epub]     CrossRef
• Potential Benefit of Metformin as Treatment for Colon Cancer: the Evidence so Far
  Azza Ali Abdelsatir, Nazik Elmalaika Husain, Abdallah Tarig Hassan, Wadie M Elmadhoun, Ahmed O Almobarak, Mohamed H Ahmed
  Asian Pacific Journal of Cancer Prevention.2016; 16(18): 8053.     CrossRef
• Weight Change and Obesity Are Associated with a Risk of Adenoma Recurrence
  Yoon Suk Jung, Jung Ho Park, Dong Il Park, Chong Il Sohn, Kyuyong Choi
  Digestive Diseases and Sciences.2016; 61(9): 2694.     CrossRef
• Associations between amount of smoking and alcohol intake and risk of colorectal neoplasm
  Yoon Suk Jung, Hwanseok Jung, Kyung Eun Yun, Seungho Ryu, Yoosoo Chang, Dong Il Park, Kyuyong Choi
  Journal of Gastroenterology and Hepatology.2016; 31(4): 788.     CrossRef
• Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer
  Jessica K. Paulus, Christina D. Williams, Furha I. Cossor, Michael J. Kelley, Robert E. Martell
  Cancer Epidemiology, Biomarkers & Prevention.2016; 25(10): 1418.     CrossRef
• Inhibitory Effect of Metformin Therapy on the Incidence of Colorectal Advanced Adenomas in Patients With Diabetes
  Yo Han Kim, Ran Noh, Sun Young Cho, Seong Jun Park, Soung Min Jeon, Hyun Deok Shin, Suk Bae Kim, Jeong Eun Shin
  Intestinal Research.2015; 13(2): 145.     CrossRef

Citations

Citations to this article as recorded by  

• Balsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-κB Signaling in HCT116 Human Colorectal Cancer Cells
  Hyun-Young Kim, Se-Lim Kim, Young-Ran Park, Yu-Chuan Liu, Seung Young Seo, Seong Hun Kim, In Hee Kim, Seung Ok Lee, Soo Teik Lee, Sang Wook Kim
  Intestinal Research.2015; 13(3): 233.     CrossRef